Autoinflammatory keratinization disease with hepatitis and autism reveals roles for JAK1 kinase hyperactivity in autoinflammation

T Takeichi, JYW Lee, Y Okuno, Y Miyasaka… - Frontiers in …, 2022 - frontiersin.org
Heterozygous mutations in JAK1 which result in JAK-STAT hyperactivity have been
implicated in an autosomal dominant disorder that features multi-organ immune …

[PDF][PDF] Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function

CN Gruber, JJA Calis, S Buta, G Evrony, JC Martin… - Immunity, 2020 - cell.com
Autoinflammatory disease can result from monogenic errors of immunity. We describe a
patient with early-onset multi-organ immune dysregulation resulting from a mosaic, gain-of …

Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis

ME Horesh, M Martin-Fernandez, C Gruber… - Journal of Experimental …, 2024 - rupress.org
Inborn errors of immunity lead to autoimmunity, inflammation, allergy, infection, and/or
malignancy. Disease-causing JAK1 gain-of-function (GoF) mutations are considered …

Mucosal epithelial Jak kinases in health and diseases

N Kumar, L Kuang, R Villa, P Kumar… - Mediators of …, 2021 - Wiley Online Library
Janus kinases (Jaks) are a family of nonreceptor tyrosine kinase that include four different
members, viz., Jak1, Jak2, Jak3, and Tyk2. Jaks play critical roles in immune cells functions; …

Successful treatment of JAK1-associated inflammatory disease

A Fayand, V Hentgen, C Posseme, C Lacout… - Journal of Allergy and …, 2023 - Elsevier
Background Gain-of-function variants of JAK1 drive a rare immune dysregulation syndrome
associated with atopic dermatitis, allergy, and eosinophilia. Objectives This study sought to …

The role of Janus kinase signaling in the pathology of atopic dermatitis

E Guttman-Yassky, AD Irvine, PM Brunner… - Journal of Allergy and …, 2023 - Elsevier
Atopic dermatitis (AD) is a heterogeneous, chronic, relapsing, inflammatory skin disease
associated with considerable physical, psychological, and economic burden. Pathology of …

[HTML][HTML] An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease

S Sabrautzki, E Janas, B Lorenz-Depiereux… - The American journal of …, 2013 - Elsevier
Within the Munich, Germany, N-ethyl-N-nitrosourea mouse mutagenesis program, we
isolated a dominant Jak1 mouse model resembling phenotypic characteristics related to …

Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome

H Baghdassarian, SA Blackstone… - … England Journal of …, 2023 - Mass Medical Soc
Background Disabling pansclerotic morphea (DPM) is a rare systemic inflammatory
disorder, characterized by poor wound healing, fibrosis, cytopenias …

Role of Janus kinase 3 in predisposition to obesity-associated metabolic syndrome

J Mishra, RK Verma, G Alpini, F Meng… - Journal of Biological …, 2015 - ASBMB
Obesity, a worldwide epidemic, is a major risk factor for the development of metabolic
syndrome (MetS) including diabetes and associated health complications. Recent studies …

JAK2 disease-risk variants are gain of function and JAK signaling threshold determines innate receptor-induced proinflammatory cytokine secretion in macrophages

M Hedl, DD Proctor, C Abraham - The Journal of Immunology, 2016 - journals.aai.org
JAK2 genetic variants are associated with inflammatory bowel disease (IBD) and JAK
inhibitors are being evaluated for therapy targeting immune-mediated diseases, including …